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Article 11

researchbriefs
The Role of NF-kappaB
Basic and translational
researchers Dr. Michael May
and Dr. Nicola Mason are
working together to evaluate
the role of NF-kappaB in canine
cancer development and the potential therapeutic use of
NBD peptide in the treatment of canine cancer.
NF-kappaB effects the regulation of genes linked to
immune responses, differentiation, cell growth, and the
death of cells. It is found in many solid tumors where
it contributes to reproduction of malignant cells and
resistance to chemotherapy of malignant cells.
This work has provided the basis for a Phase I
clinical trial to evaluate the effects of NBD peptide on
NF-kappaB activity in dogs with relapsed, drug-resistant
lymphoma. Further details of the clinical trial can be
found at http://research.vet.upenn.edu/vcic.
While this trial is specifically for canine patients with
lymphoma, the clinical, biological and genetic similarities
between canine lymphoma and Non-Hodgkin’s lymphoma
(NHL) in humans indicates that findings in dogs may
provide valuable information for humans with NHL.

Penn Shelter Canine
Mammary Tumor Program
A team of clinicians at the Matthew
J. Ryan Veterinary Hospital led by
Dr. Karin Sorenmo, Dr. Michael
Goldschmidt, Dr. David Holt
and Dr. Michael Moyer, V’90, Rosenthal Director of
Penn’s Shelter Medicine Program, received funding from
Reid and Krista Buerger to study similarities between canine
mammary tumors and breast cancer in women.
Mammary gland tumors remain the most common
tumors in intact female dogs and represent a common cause
of disease and premature death in dogs around the world.
Studies have identified many similarities between canine
mammary tumors and breast cancer in women in terms
of epidemiology, biology, dietary risk factors and clinical
behavior, as well as hormonal association. The development
of mammary tumors in dogs is dependent on exposure to
ovarian hormones and the tumor risk can be significantly
reduced by spaying at an early age. The risk for developing
breast cancer in women is also associated with the
cumulative exposure to bio-available estrogens, suggesting
that similar hormone-driven mechanisms might be linked
with breast cancer development in both species.

With Wise and Thoughtful Planning,
We All Have the Power to Make History
Gifts that fund the future of Penn Veterinary Medicine
Plan a gift today that can provide for the future of Penn by including a charitable
bequest as part of your long term planning. It’s as easy as naming Penn Vet as a
beneficiary of your will, retirement plan or life insurance policy.

Benefits of a Bequest Include:
• Establishes a lasting legacy
• Enables you to make a significant contribution that may otherwise not have been
possible during your lifetime
• The value of the estate intention is removed from your taxable estate
Most importantly, it offers the satisfaction of knowing your commitment will

truly make a difference for the future of Penn Vet.
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If you have already included Penn as part
of your estate plan, or if you would like
information on ways to do so, contact:

Lynn Ierardi, J.D.
800.223.8236
lierardi@dev.upenn.edu
www.upenn.planyourlegacy.org

Your gift qualifies you for membership in the
Charles Custis Harrison Society.

